Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-39393406 in unipolar or bipolar depression
NCT02677207Phase 2Completed
- Sponsor
- Tangent Data
- Start
- Feb 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of JNJ-39393406 in major depressive disorder (MDD), bipolar disorder (BD), sponsored by Tangent Data. Started Feb 2016; status: completed.
02
Drugs
JNJ-39393406
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02677207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02677207.